aluates Reports

$ 0.0

Automative

Global Yellow Fever Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-19N9092

Global Yellow Fever Vaccines Market Outlook 2022

BUY CHAPTERS

Global Yellow Fever Vaccines Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-19N9092

Report

August 2025

Pages:72

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur

Bio-Manguinhos

FSUE Chumakov

Institut Pasteur de Dakar

Yellow Fever Vaccines Sales Market Size

The global Yellow Fever Vaccines market size was US$ 140 million in 2024 and is forecast to a readjusted size of US$ 186 million by 2031 with a CAGR of 4.2% during the forecast period 2025-2031.

Yellow Fever Vaccines Sales Market

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Yellow Fever Vaccines market competitiveness, regional economic performance, and supply chain configurations.

Yellow fever vaccine is a vaccine that can prevent yellow fever. The vaccination targets are people who enter or pass through the epidemic area.

The global Yellow Fever Vaccines market is primarily driven by the increasing risk of yellow fever outbreaks, particularly in endemic regions such as sub-Saharan Africa and parts of South America. Growing international travel and global mobility have heightened the need for preventive vaccination, especially in travelers visiting high-risk areas. Government-led immunization programs and World Health Organization (WHO) initiatives, such as the Eliminate Yellow Fever Epidemics (EYE) strategy, also contribute to increased vaccine demand. Moreover, rising public health awareness and emergency stockpiling by international health agencies are enhancing market growth, with mass vaccination campaigns being conducted to prevent potential epidemics.

Despite the demand, the Yellow Fever Vaccines market faces several significant challenges. Limited global manufacturing capacity can lead to supply shortages during epidemic surges, causing delays in immunization programs. The vaccine requires cold chain logistics and must be stored at controlled temperatures, which poses distribution challenges in low-resource settings. Additionally, adverse reactions to the live-attenuated vaccine—though rare—can affect public perception and vaccination uptake. Regulatory hurdles and the long timeline for clinical trials and approval of newer formulations or alternatives also slow down market expansion, especially as newer manufacturers attempt to enter the space.

Emerging trends in the Yellow Fever Vaccines market include increased public-private partnerships to scale up vaccine production and improve distribution infrastructure. Technological advancements are pushing toward the development of thermostable formulations to overcome cold chain barriers. There is also rising investment in regional vaccine manufacturing hubs, particularly in Africa, to reduce reliance on global supply chains. Enhanced surveillance systems, digital vaccination records, and integration of yellow fever vaccines into routine immunization schedules are improving coverage rates. Moreover, the expansion of travel-related vaccine requirements and efforts to ensure universal access in endemic regions are expected to drive long-term market growth.

Global Yellow Fever Vaccines key players include Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, etc. Global top three manufacturers hold a share about 90%. Middle East and Africa is the largest market, with a share about 70%, followed by South America, and Europe, both have a share about 30 percent. In terms of application, the largest application is Routine Immunization, followed by Travelers.

The global Yellow Fever Vaccines market is strategically segmented by company, region (country), by Distribution Channel, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Distribution Channel, and by Application for 2020-2031.

Market Segmentation

Scope of Yellow Fever Vaccines Sales Market Report

Report Metric	Details
Report Name	Yellow Fever Vaccines Sales Market
Forecasted market size in 2031	US$ 186 million
CAGR	4.2%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Institonal Contributions Private Purchase Others
By Application: (Core Demand Driver vs Emerging Opportunity)	Routine Immunization Travelers Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Yellow Fever Vaccines market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Private Purchase in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Travelers in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Institonal Contributions dominance in Europe vs. Private Purchase demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.

FAQ for this report

What is the Yellow Fever Vaccines Sales Market size in 2031?

Ans: The Yellow Fever Vaccines Sales Market size in 2031 will be US$ 186 million.

What is the market share of major companies in Yellow Fever Vaccines Sales Market?

Ans: Global top three manufacturers hold a share about 90%.

Who are the main players in the Yellow Fever Vaccines Sales Market report?

Ans: The main players in the Yellow Fever Vaccines Sales Market are Sanofi Pasteur, Bio-Manguinhos, FSUE Chumakov, Institut Pasteur de Dakar

What are the Application segmentation covered in the Yellow Fever Vaccines Sales Market report?

Ans: The Applications covered in the Yellow Fever Vaccines Sales Market report are Routine Immunization, Travelers, Other

What are the Type segmentation covered in the Yellow Fever Vaccines Sales Market report?

Ans: The Types covered in the Yellow Fever Vaccines Sales Market report are Institonal Contributions, Private Purchase, Others

1 Market Overview

1.1 Yellow Fever Vaccines Product Scope

1.2 Yellow Fever Vaccines by Distribution Channel

1.2.1 Global Yellow Fever Vaccines Sales by Distribution Channel (2020 & 2024 & 2031)

1.2.2 Institonal Contributions

1.2.3 Private Purchase

1.2.4 Others

1.3 Yellow Fever Vaccines by Application

1.3.1 Global Yellow Fever Vaccines Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Routine Immunization

1.3.3 Travelers

1.3.4 Other

1.4 Global Yellow Fever Vaccines Market Estimates and Forecasts (2020-2031)

1.4.1 Global Yellow Fever Vaccines Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Yellow Fever Vaccines Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Yellow Fever Vaccines Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Yellow Fever Vaccines Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Yellow Fever Vaccines Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Yellow Fever Vaccines Sales Market Share by Region (2020-2025)

2.2.2 Global Yellow Fever Vaccines Revenue Market Share by Region (2020-2025)

2.3 Global Yellow Fever Vaccines Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Yellow Fever Vaccines Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Yellow Fever Vaccines Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 Europe Yellow Fever Vaccines Market Size and Prospective (2020-2031)

2.4.2 South America Yellow Fever Vaccines Market Size and Prospective (2020-2031)

2.4.3 Africa Yellow Fever Vaccines Market Size and Prospective (2020-2031)

3 Global Market Size by Distribution Channel

3.1 Global Yellow Fever Vaccines Historic Market Review by Distribution Channel (2020-2025)

3.1.1 Global Yellow Fever Vaccines Sales by Distribution Channel (2020-2025)

3.1.2 Global Yellow Fever Vaccines Revenue by Distribution Channel (2020-2025)

3.1.3 Global Yellow Fever Vaccines Price by Distribution Channel (2020-2025)

3.2 Global Yellow Fever Vaccines Market Estimates and Forecasts by Distribution Channel (2026-2031)

3.2.1 Global Yellow Fever Vaccines Sales Forecast by Distribution Channel (2026-2031)

3.2.2 Global Yellow Fever Vaccines Revenue Forecast by Distribution Channel (2026-2031)

3.2.3 Global Yellow Fever Vaccines Price Forecast by Distribution Channel (2026-2031)

3.3 Different Types Yellow Fever Vaccines Representative Players

4 Global Market Size by Application

4.1 Global Yellow Fever Vaccines Historic Market Review by Application (2020-2025)

4.1.1 Global Yellow Fever Vaccines Sales by Application (2020-2025)

4.1.2 Global Yellow Fever Vaccines Revenue by Application (2020-2025)

4.1.3 Global Yellow Fever Vaccines Price by Application (2020-2025)

4.2 Global Yellow Fever Vaccines Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Yellow Fever Vaccines Sales Forecast by Application (2026-2031)

4.2.2 Global Yellow Fever Vaccines Revenue Forecast by Application (2026-2031)

4.2.3 Global Yellow Fever Vaccines Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Yellow Fever Vaccines Application

5 Competition Landscape by Players

5.1 Global Yellow Fever Vaccines Sales by Players (2020-2025)

5.2 Global Top Yellow Fever Vaccines Players by Revenue (2020-2025)

5.3 Global Yellow Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Yellow Fever Vaccines as of 2024)

5.4 Global Yellow Fever Vaccines Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Yellow Fever Vaccines, Product Type & Application

5.7 Global Key Manufacturers of Yellow Fever Vaccines, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 Europe Market: Players, Segments, Downstream and Major Customers

6.1.1 Europe Yellow Fever Vaccines Sales by Company

6.1.1.1 Europe Yellow Fever Vaccines Sales by Company (2020-2025)

6.1.1.2 Europe Yellow Fever Vaccines Revenue by Company (2020-2025)

6.1.2 Europe Yellow Fever Vaccines Sales Breakdown by Distribution Channel (2020-2025)

6.1.3 Europe Yellow Fever Vaccines Sales Breakdown by Application (2020-2025)

6.1.4 Europe Yellow Fever Vaccines Major Customer

6.1.5 Europe Market Trend and Opportunities

6.2 South America Market: Players, Segments, Downstream and Major Customers

6.2.1 South America Yellow Fever Vaccines Sales by Company

6.2.1.1 South America Yellow Fever Vaccines Sales by Company (2020-2025)

6.2.1.2 South America Yellow Fever Vaccines Revenue by Company (2020-2025)

6.2.2 South America Yellow Fever Vaccines Sales Breakdown by Distribution Channel (2020-2025)

6.2.3 South America Yellow Fever Vaccines Sales Breakdown by Application (2020-2025)

6.2.4 South America Yellow Fever Vaccines Major Customer

6.2.5 South America Market Trend and Opportunities

6.3 Africa Market: Players, Segments, Downstream and Major Customers

6.3.1 Africa Yellow Fever Vaccines Sales by Company

6.3.1.1 Africa Yellow Fever Vaccines Sales by Company (2020-2025)

6.3.1.2 Africa Yellow Fever Vaccines Revenue by Company (2020-2025)

6.3.2 Africa Yellow Fever Vaccines Sales Breakdown by Distribution Channel (2020-2025)

6.3.3 Africa Yellow Fever Vaccines Sales Breakdown by Application (2020-2025)

6.3.4 Africa Yellow Fever Vaccines Major Customer

6.3.5 Africa Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Sanofi Pasteur

7.1.1 Sanofi Pasteur Company Information

7.1.2 Sanofi Pasteur Business Overview

7.1.3 Sanofi Pasteur Yellow Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Sanofi Pasteur Yellow Fever Vaccines Products Offered

7.1.5 Sanofi Pasteur Recent Development

7.2 Bio-Manguinhos

7.2.1 Bio-Manguinhos Company Information

7.2.2 Bio-Manguinhos Business Overview

7.2.3 Bio-Manguinhos Yellow Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Bio-Manguinhos Yellow Fever Vaccines Products Offered

7.2.5 Bio-Manguinhos Recent Development

7.3 FSUE Chumakov

7.3.1 FSUE Chumakov Company Information

7.3.2 FSUE Chumakov Business Overview

7.3.3 FSUE Chumakov Yellow Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)

7.3.4 FSUE Chumakov Yellow Fever Vaccines Products Offered

7.3.5 FSUE Chumakov Recent Development

7.4 Institut Pasteur de Dakar

7.4.1 Institut Pasteur de Dakar Company Information

7.4.2 Institut Pasteur de Dakar Business Overview

7.4.3 Institut Pasteur de Dakar Yellow Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Institut Pasteur de Dakar Yellow Fever Vaccines Products Offered

7.4.5 Institut Pasteur de Dakar Recent Development

8 Yellow Fever Vaccines Manufacturing Cost Analysis

8.1 Yellow Fever Vaccines Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Yellow Fever Vaccines

8.4 Yellow Fever Vaccines Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Yellow Fever Vaccines Distributors List

9.3 Yellow Fever Vaccines Customers

10 Yellow Fever Vaccines Market Dynamics

10.1 Yellow Fever Vaccines Industry Trends

10.2 Yellow Fever Vaccines Market Drivers

10.3 Yellow Fever Vaccines Market Challenges

10.4 Yellow Fever Vaccines Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur

Bio-Manguinhos

FSUE Chumakov

Institut Pasteur de Dakar

List of Tables

Table 1. Global Yellow Fever Vaccines Sales (US$ Million) Growth Rate by Distribution Channel (2020 & 2024 & 2031)

Table 2. Global Yellow Fever Vaccines Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Yellow Fever Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Yellow Fever Vaccines Sales (K Units) by Region (2020-2025)

Table 5. Global Yellow Fever Vaccines Sales Market Share by Region (2020-2025)

Table 6. Global Yellow Fever Vaccines Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Yellow Fever Vaccines Revenue Share by Region (2020-2025)

Table 8. Global Yellow Fever Vaccines Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Yellow Fever Vaccines Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Yellow Fever Vaccines Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Yellow Fever Vaccines Revenue Share Forecast by Region (2026-2031)

Table 12. Global Yellow Fever Vaccines Sales by Distribution Channel (K Units) & (2020-2025)

Table 13. Global Yellow Fever Vaccines Sales Share by Distribution Channel (2020-2025)

Table 14. Global Yellow Fever Vaccines Revenue by Distribution Channel (US$ Million) & (2020-2025)

Table 15. Global Yellow Fever Vaccines Price by Distribution Channel (US$/Unit) & (2020-2025)

Table 16. Global Yellow Fever Vaccines Sales by Distribution Channel (K Units) & (2026-2031)

Table 17. Global Yellow Fever Vaccines Revenue by Distribution Channel (US$ Million) & (2026-2031)

Table 18. Global Yellow Fever Vaccines Price by Distribution Channel (US$/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Yellow Fever Vaccines Sales by Application (K Units) & (2020-2025)

Table 21. Global Yellow Fever Vaccines Sales Share by Application (2020-2025)

Table 22. Global Yellow Fever Vaccines Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Yellow Fever Vaccines Price by Application (US$/Unit) & (2020-2025)

Table 24. Global Yellow Fever Vaccines Sales by Application (K Units) & (2026-2031)

Table 25. Global Yellow Fever Vaccines Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Yellow Fever Vaccines Price by Application (US$/Unit) & (2026-2031)

Table 27. New Sources of Growth in Yellow Fever Vaccines Application

Table 28. Global Yellow Fever Vaccines Sales by Company (K Units) & (2020-2025)

Table 29. Global Yellow Fever Vaccines Sales Share by Company (2020-2025)

Table 30. Global Yellow Fever Vaccines Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Yellow Fever Vaccines Revenue Share by Company (2020-2025)

Table 32. Global Yellow Fever Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Yellow Fever Vaccines as of 2024)

Table 33. Global Market Yellow Fever Vaccines Average Price by Company (US$/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Yellow Fever Vaccines, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Yellow Fever Vaccines, Product Type & Application

Table 36. Global Key Manufacturers of Yellow Fever Vaccines, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. Europe Yellow Fever Vaccines Sales by Company (2020-2025) & (K Units)

Table 39. Europe Yellow Fever Vaccines Sales Market Share by Company (2020-2025)

Table 40. Europe Yellow Fever Vaccines Revenue by Company (2020-2025) & (US$ Million)

Table 41. Europe Yellow Fever Vaccines Revenue Market Share by Company (2020-2025)

Table 42. Europe Yellow Fever Vaccines Sales by Distribution Channel (2020-2025) & (K Units)

Table 43. Europe Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2025)

Table 44. Europe Yellow Fever Vaccines Sales by Application (2020-2025) & (K Units)

Table 45. Europe Yellow Fever Vaccines Sales Market Share by Application (2020-2025)

Table 46. South America Yellow Fever Vaccines Sales by Company (2020-2025) & (K Units)

Table 47. South America Yellow Fever Vaccines Sales Market Share by Company (2020-2025)

Table 48. South America Yellow Fever Vaccines Revenue by Company (2020-2025) & (US$ Million)

Table 49. South America Yellow Fever Vaccines Revenue Market Share by Company (2020-2025)

Table 50. South America Yellow Fever Vaccines Sales by Distribution Channel (2020-2025) & (K Units)

Table 51. South America Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2025)

Table 52. South America Yellow Fever Vaccines Sales by Application (2020-2025) & (K Units)

Table 53. South America Yellow Fever Vaccines Sales Market Share by Application (2020-2025)

Table 54. Africa Yellow Fever Vaccines Sales by Company (2020-2025) & (K Units)

Table 55. Africa Yellow Fever Vaccines Sales Market Share by Company (2020-2025)

Table 56. Africa Yellow Fever Vaccines Revenue by Company (2020-2025) & (US$ Million)

Table 57. Africa Yellow Fever Vaccines Revenue Market Share by Company (2020-2025)

Table 58. Africa Yellow Fever Vaccines Sales by Distribution Channel (2020-2025) & (K Units)

Table 59. Africa Yellow Fever Vaccines Sales Market Share by Distribution Channel (2020-2025)

Table 60. Africa Yellow Fever Vaccines Sales by Application (2020-2025) & (K Units)

Table 61. Africa Yellow Fever Vaccines Sales Market Share by Application (2020-2025)

Table 62. Sanofi Pasteur Company Information

Table 63. Sanofi Pasteur Description and Business Overview

Table 64. Sanofi Pasteur Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Sanofi Pasteur Yellow Fever Vaccines Product

Table 66. Sanofi Pasteur Recent Development

Table 67. Bio-Manguinhos Company Information

Table 68. Bio-Manguinhos Description and Business Overview

Table 69. Bio-Manguinhos Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Bio-Manguinhos Yellow Fever Vaccines Product

Table 71. Bio-Manguinhos Recent Development

Table 72. FSUE Chumakov Company Information

Table 73. FSUE Chumakov Description and Business Overview

Table 74. FSUE Chumakov Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. FSUE Chumakov Yellow Fever Vaccines Product

Table 76. FSUE Chumakov Recent Development

Table 77. Institut Pasteur de Dakar Company Information

Table 78. Institut Pasteur de Dakar Description and Business Overview

Table 79. Institut Pasteur de Dakar Yellow Fever Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Institut Pasteur de Dakar Yellow Fever Vaccines Product

Table 81. Institut Pasteur de Dakar Recent Development

Table 82. Production Base and Market Concentration Rate of Raw Material

Table 83. Key Suppliers of Raw Materials

Table 84. Yellow Fever Vaccines Distributors List

Table 85. Yellow Fever Vaccines Customers List

Table 86. Yellow Fever Vaccines Market Trends

Table 87. Yellow Fever Vaccines Market Drivers

Table 88. Yellow Fever Vaccines Market Challenges

Table 89. Yellow Fever Vaccines Market Restraints

Table 90. Research Programs/Design for This Report

Table 91. Key Data Information from Secondary Sources

Table 92. Key Data Information from Primary Sources

List of Figures

Figure 1. Yellow Fever Vaccines Product Picture

Figure 2. Global Yellow Fever Vaccines Sales (US$ Million) by Distribution Channel (2020 & 2024 & 2031)

Figure 3. Global Yellow Fever Vaccines Sales Market Share by Distribution Channel in 2024 & 2031

Figure 4. Institonal Contributions Product Picture

Figure 5. Private Purchase Product Picture

Figure 6. Others Product Picture

Figure 7. Global Yellow Fever Vaccines Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Yellow Fever Vaccines Sales Market Share by Application in 2024 & 2031

Figure 9. Routine Immunization Examples

Figure 10. Travelers Examples

Figure 11. Other Examples

Figure 12. Global Yellow Fever Vaccines Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Yellow Fever Vaccines Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Yellow Fever Vaccines Sales (K Units) Growth Rate (2020-2031)

Figure 15. Global Yellow Fever Vaccines Price Trends Growth Rate (2020-2031) & (US$/Unit)

Figure 16. Yellow Fever Vaccines Report Years Considered

Figure 17. Global Market Yellow Fever Vaccines Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Yellow Fever Vaccines Revenue Market Share by Region: 2020 VS 2024

Figure 19. Europe Yellow Fever Vaccines Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Europe Yellow Fever Vaccines Sales (K Units) Growth Rate (2020-2031)

Figure 21. South America Yellow Fever Vaccines Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. South America Yellow Fever Vaccines Sales (K Units) Growth Rate (2020-2031)

Figure 23. Africa Yellow Fever Vaccines Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. Africa Yellow Fever Vaccines Sales (K Units) Growth Rate (2020-2031)

Figure 25. Global Yellow Fever Vaccines Revenue Share by Distribution Channel (2020-2025)

Figure 26. Global Yellow Fever Vaccines Sales Share by Distribution Channel (2026-2031)

Figure 27. Global Yellow Fever Vaccines Revenue Share by Distribution Channel (2026-2031)

Figure 28. Global Yellow Fever Vaccines Revenue Share by Application (2020-2025)

Figure 29. Global Yellow Fever Vaccines Revenue Growth Rate by Application in 2020 & 2024

Figure 30. Global Yellow Fever Vaccines Sales Share by Application (2026-2031)

Figure 31. Global Yellow Fever Vaccines Revenue Share by Application (2026-2031)

Figure 32. Global Yellow Fever Vaccines Sales Share by Company (2024)

Figure 33. Global Yellow Fever Vaccines Revenue Share by Company (2024)

Figure 34. Global 5 Largest Yellow Fever Vaccines Players Market Share by Revenue in Yellow Fever Vaccines: 2020 & 2024

Figure 35. Yellow Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 36. Manufacturing Cost Structure of Yellow Fever Vaccines

Figure 37. Manufacturing Process Analysis of Yellow Fever Vaccines

Figure 38. Yellow Fever Vaccines Industrial Chain

Figure 39. Channels of Distribution (Direct Vs Distribution)

Figure 40. Distributors Profiles

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6000

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8000

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Yellow Fever Treatment Market Research Report 2024

Global Yellow Fever Virus Testing Market Research Report 2024

Global Yellow Fever Virus Test Kit Market Research Report 2024

Encephalitis Vaccination Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Animal Vaccines Market Insights Forecast to 2030

Global Poultry Vaccines Market Research Report 2025

Global Preventive Vaccines Market Insights Forecast to 2030

Malaria Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Travel Vaccines Market Insights Forecast to 2030

Hepatitis B Vaccine Recombinant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccines For Children Market Insights Forecast to 2030

Disease Control and Prevention Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Newcastle Disease Vaccine Market Research Report 2025

Global Yellow Fever Virus Nucleic Acid Detection Kit Market Research Report 2024

Meningitis B Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pneumococcal Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions